Selected article for: "death endpoint and mechanical ventilation"

Author: Aguirre-García, Gloria Mayela; Ramonfaur, Diego; Torre-Amione, Guillermo; Ramírez-Elizondo, María Teresa; Lara-Medrano, Reynaldo; Moreno-Hoyos, Juan Francisco; Velázquez-Ávila, Edna Sophia; Diaz-Garza, Carlos Andres; Sanchez-Nava, Victor M.; Castilleja-Leal, Fernando; Rhoades, Gerald M.; Martínez-Reséndez, Michel Fernando
Title: Stratifying Risk Outcomes Among Adult COVID-19 Inpatients with High Flow Oxygen: The R4 Score
  • Cord-id: 19d29mnp
  • Document date: 2021_10_12
  • ID: 19d29mnp
    Snippet: BACKGROUND: High flow oxygen therapy (HFO) is a widely used intervention for pulmonary complications. Amid the coronavirus infectious disease 2019 (COVID-19) pandemic, HFO became a popular alternative to conventional oxygen supplementation therapies. Risk stratification tools have been repurposed –and new ones developed– to estimate outcome risks among COVID-19 patients. This study aims to provide a simple risk stratification system to predict invasive mechanical ventilation (IMV) or death a
    Document: BACKGROUND: High flow oxygen therapy (HFO) is a widely used intervention for pulmonary complications. Amid the coronavirus infectious disease 2019 (COVID-19) pandemic, HFO became a popular alternative to conventional oxygen supplementation therapies. Risk stratification tools have been repurposed –and new ones developed– to estimate outcome risks among COVID-19 patients. This study aims to provide a simple risk stratification system to predict invasive mechanical ventilation (IMV) or death among COVID-19 inpatients on HFO. METHODS: Among 529 adult inpatients with COVID-19 pneumonia, we selected unadjusted clinical risk factors for developing the composite endpoint of IMV or death. The risk for the primary outcome by each category was estimated using a Cox proportional hazards model. Bootstrapping was used to validate the results. RESULTS: Age above 62, eGFR under 60 ml/min, room air SpO2 ≤89 % upon admission, history of hypertension, history of diabetes, and any comorbidity (cancer, cardiovascular disease, COPD/ asthma, hypothyroidism, or autoimmune disease) were considered for the score. Each of the six criteria scored 1 point. The score was further simplified into 4 categories: 1) 0 criteria, 2) 1 criterion, 3) 2-3 criteria, and 4) ≥4 criteria. Taking the first category as the reference, risk estimates for the primary endpoint were HR; 2.94 [1.67 – 5.26], 4.08 [2.63 – 7.05], and 6.63 [3.74 – 11.77], respectively. In ROC analysis, the AUC for the model was 0.72. CONCLUSIONS: Our score uses simple criteria to estimate the risk for IMV or death among COVID-19 inpatients with HFO. Higher category reflects consistent increases in risk for the endpoint.

    Search related documents:
    Co phrase search for related documents
    • acute myocardial infarction and low prevalence: 1, 2, 3, 4
    • acute respiratory distress syndrome and admission prior: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute respiratory distress syndrome and admission receive: 1, 2, 3
    • acute respiratory distress syndrome and admission record: 1, 2
    • acute respiratory distress syndrome and admission room air oxygen saturation: 1, 2, 3
    • acute respiratory distress syndrome and low frequency: 1
    • acute respiratory distress syndrome and low prevalence: 1, 2, 3, 4, 5, 6
    • acute respiratory failure and admission prior: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute respiratory failure and admission receive: 1
    • acute respiratory failure and low frequency: 1, 2
    • acute respiratory failure and low prevalence: 1, 2, 3
    • admission prior and low prevalence: 1, 2